Annual Total Assets
$777.88 M
+$53.71 M+7.42%
December 31, 2023
Summary
- As of February 7, 2025, FOLD annual total assets is $777.88 million, with the most recent change of +$53.71 million (+7.42%) on December 31, 2023.
- During the last 3 years, FOLD annual total assets has fallen by -$108.64 million (-12.25%).
- FOLD annual total assets is now -24.98% below its all-time high of $1.04 billion, reached on December 30, 2016.
Performance
FOLD Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$786.56 M
+$37.07 M+4.95%
September 30, 2024
Summary
- As of February 7, 2025, FOLD quarterly total assets is $786.56 million, with the most recent change of +$37.07 million (+4.95%) on September 30, 2024.
- Over the past year, FOLD quarterly total assets has increased by +$22.47 million (+2.94%).
- FOLD quarterly total assets is now -24.14% below its all-time high of $1.04 billion, reached on December 30, 2016.
Performance
FOLD Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
FOLD Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.4% | +2.9% |
| 3 y3 years | -12.3% | +2.9% |
| 5 y5 years | -1.5% | +2.9% |
FOLD Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.1% | +7.4% | -13.1% | +12.3% |
| 5 y | 5-year | -14.1% | +7.4% | -17.8% | +12.3% |
| alltime | all time | -25.0% | >+9999.0% | -24.1% | +2643.5% |
Amicus Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $786.56 M(+4.9%) |
| Jun 2024 | - | $749.48 M(+3.8%) |
| Mar 2024 | - | $721.79 M(-7.2%) |
| Dec 2023 | $777.88 M(+7.4%) | $777.88 M(+1.8%) |
| Sep 2023 | - | $764.08 M(+4.7%) |
| Jun 2023 | - | $730.09 M(+4.2%) |
| Mar 2023 | - | $700.52 M(-3.3%) |
| Dec 2022 | $724.17 M(-20.0%) | $724.17 M(-4.7%) |
| Sep 2022 | - | $759.53 M(-5.1%) |
| Jun 2022 | - | $800.59 M(-3.2%) |
| Mar 2022 | - | $826.94 M(-8.6%) |
| Dec 2021 | $905.14 M(+2.1%) | $905.14 M(-5.4%) |
| Sep 2021 | - | $956.67 M(+21.6%) |
| Jun 2021 | - | $786.89 M(-2.9%) |
| Mar 2021 | - | $810.03 M(-8.6%) |
| Dec 2020 | $886.52 M(+4.3%) | $886.52 M(-1.6%) |
| Sep 2020 | - | $900.54 M(+28.4%) |
| Jun 2020 | - | $701.45 M(-5.0%) |
| Mar 2020 | - | $738.35 M(-13.2%) |
| Dec 2019 | $850.21 M(+7.6%) | $850.21 M(-3.6%) |
| Sep 2019 | - | $882.29 M(-3.9%) |
| Jun 2019 | - | $918.03 M(+20.1%) |
| Mar 2019 | - | $764.70 M(-3.2%) |
| Dec 2018 | $789.95 M(+26.0%) | $789.95 M(-5.8%) |
| Sep 2018 | - | $838.59 M(+1.5%) |
| Jun 2018 | - | $825.89 M(-5.1%) |
| Mar 2018 | - | $870.00 M(+38.8%) |
| Dec 2017 | $627.02 M(-39.5%) | $627.02 M(-7.9%) |
| Sep 2017 | - | $680.78 M(-27.5%) |
| Jun 2017 | - | $938.97 M(-5.5%) |
| Mar 2017 | - | $993.38 M(-4.2%) |
| Dec 2016 | $1.04 B(+14.1%) | $1.04 B(+12.9%) |
| Sep 2016 | - | $918.18 M(+0.5%) |
| Jun 2016 | - | $914.01 M(+5.9%) |
| Mar 2016 | - | $862.91 M(-5.0%) |
| Dec 2015 | $908.38 M | $908.38 M(-7.9%) |
| Sep 2015 | - | $986.69 M(+144.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $403.91 M(+109.7%) |
| Mar 2015 | - | $192.62 M(-8.3%) |
| Dec 2014 | $209.97 M(+64.6%) | $209.97 M(+67.3%) |
| Sep 2014 | - | $125.49 M(+6.4%) |
| Jun 2014 | - | $117.99 M(+5.0%) |
| Mar 2014 | - | $112.36 M(-11.9%) |
| Dec 2013 | $127.56 M(+15.9%) | $127.56 M(+84.6%) |
| Sep 2013 | - | $69.11 M(-16.1%) |
| Jun 2013 | - | $82.33 M(-11.7%) |
| Mar 2013 | - | $93.22 M(-15.3%) |
| Dec 2012 | $110.09 M(+57.7%) | $110.09 M(-6.9%) |
| Sep 2012 | - | $118.21 M(+5.9%) |
| Jun 2012 | - | $111.60 M(-7.6%) |
| Mar 2012 | - | $120.80 M(+73.1%) |
| Dec 2011 | $69.80 M(-38.0%) | $69.80 M(-11.5%) |
| Sep 2011 | - | $78.87 M(-12.6%) |
| Jun 2011 | - | $90.29 M(-12.0%) |
| Mar 2011 | - | $102.55 M(-8.9%) |
| Dec 2010 | $112.55 M(+31.8%) | $112.55 M(+76.5%) |
| Sep 2010 | - | $63.76 M(-14.9%) |
| Jun 2010 | - | $74.89 M(-15.0%) |
| Mar 2010 | - | $88.14 M(+3.2%) |
| Dec 2009 | $85.37 M(-33.7%) | $85.37 M(-13.7%) |
| Sep 2009 | - | $98.89 M(-9.0%) |
| Jun 2009 | - | $108.68 M(-6.6%) |
| Mar 2009 | - | $116.38 M(-9.6%) |
| Dec 2008 | $128.77 M(-22.9%) | $128.77 M(-10.1%) |
| Sep 2008 | - | $143.16 M(-5.2%) |
| Jun 2008 | - | $151.08 M(-5.3%) |
| Mar 2008 | - | $159.53 M(-4.5%) |
| Dec 2007 | $167.10 M(+180.2%) | $167.10 M(+33.9%) |
| Sep 2007 | - | $124.83 M(-5.1%) |
| Jun 2007 | - | $131.58 M(+80.1%) |
| Mar 2007 | - | $73.05 M(+22.5%) |
| Dec 2006 | $59.65 M(+108.0%) | $59.65 M(+108.0%) |
| Dec 2005 | $28.67 M(+5622.6%) | $28.67 M |
| Dec 2003 | $501.00 K | - |
FAQ
- What is Amicus Therapeutics annual total assets?
- What is the all time high annual total assets for Amicus Therapeutics?
- What is Amicus Therapeutics annual total assets year-on-year change?
- What is Amicus Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly total assets year-on-year change?
What is Amicus Therapeutics annual total assets?
The current annual total assets of FOLD is $777.88 M
What is the all time high annual total assets for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total assets is $1.04 B
What is Amicus Therapeutics annual total assets year-on-year change?
Over the past year, FOLD annual total assets has changed by +$53.71 M (+7.42%)
What is Amicus Therapeutics quarterly total assets?
The current quarterly total assets of FOLD is $786.56 M
What is the all time high quarterly total assets for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total assets is $1.04 B
What is Amicus Therapeutics quarterly total assets year-on-year change?
Over the past year, FOLD quarterly total assets has changed by +$22.47 M (+2.94%)